A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytes.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
05 2019
Historique:
received: 21 11 2018
revised: 01 02 2019
accepted: 08 02 2019
pubmed: 12 2 2019
medline: 10 3 2020
entrez: 12 2 2019
Statut: ppublish

Résumé

Constitutional mismatch repair deficiency (CMMRD) is caused by germline pathogenic variants in both alleles of a mismatch repair gene. Patients have an exceptionally high risk of numerous pediatric malignancies and benefit from surveillance and adjusted treatment. The diversity of its manifestation, and ambiguous genotyping results, particularly from PMS2, can complicate diagnosis and preclude timely patient management. Assessment of low-level microsatellite instability in nonneoplastic tissues can detect CMMRD, but current techniques are laborious or of limited sensitivity. Here, we present a simple, scalable CMMRD diagnostic assay. It uses sequencing and molecular barcodes to detect low-frequency microsatellite variants in peripheral blood leukocytes and classifies samples using variant frequencies. We tested 30 samples from 26 genetically-confirmed CMMRD patients, and samples from 94 controls and 40 Lynch syndrome patients. All samples were correctly classified, except one from a CMMRD patient recovering from aplasia. However, additional samples from this same patient tested positive for CMMRD. The assay also confirmed CMMRD in six suspected patients. The assay is suitable for both rapid CMMRD diagnosis within clinical decision windows and scalable screening of at-risk populations. Its deployment will improve patient care, and better define the prevalence and phenotype of this likely underreported cancer syndrome.

Identifiants

pubmed: 30740824
doi: 10.1002/humu.23721
pmc: PMC6519362
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

649-655

Subventions

Organisme : Cancer Research UK
ID : C569/A24991
Pays : United Kingdom
Organisme : The Barbour Foundation
ID : 328081
Pays : International
Organisme : The Barbour Foundation
ID : NA
Pays : International
Organisme : AsCaP Catalyst Award
Pays : International
Organisme : CaPP3 Clinical Research Committee Late Phase Award
ID : A15934
Pays : International
Organisme : Dutch Cancer Society
ID : UL-2012-5515
Pays : International

Informations de copyright

© 2019 The Authors. Human Mutation Published by Wiley Periodicals, Inc.

Références

J Med Genet. 2014 Jun;51(6):355-65
pubmed: 24737826
PLoS One. 2018 Aug 29;13(8):e0203052
pubmed: 30157243
Mech Ageing Dev. 2005 Oct;126(10):1051-9
pubmed: 16098563
J Pediatr. 2006 Jun;148(6):837-9
pubmed: 16769400
J Med Genet. 2019 Feb;56(2):53-62
pubmed: 30415209
Hum Mutat. 2008 Feb;29(2):299-305
pubmed: 18030674
Am J Hum Genet. 2004 May;74(5):954-64
pubmed: 15077197
Blood. 2003 Sep 1;102(5):1626-33
pubmed: 12730104
Clin Cancer Res. 2017 Jun 1;23(11):e32-e37
pubmed: 28572265
Nature. 2018 Mar 15;555(7696):321-327
pubmed: 29489754
Eur J Hum Genet. 2018 Oct;26(10):1417-1423
pubmed: 29904176
J Clin Oncol. 2018 Oct 10;36(29):2961-2968
pubmed: 30161022
Hum Mutat. 2010 Mar;31(3):317-24
pubmed: 20052760
Gastrointest Endosc. 2017 May;85(5):873-882
pubmed: 28363411
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
J Clin Oncol. 2016 Jul 1;34(19):2206-11
pubmed: 27001570
Hum Mutat. 2019 May;40(5):649-655
pubmed: 30740824
Genet Med. 2016 Dec;18(12):1282-1289
pubmed: 27228465
J Med Genet. 2015 May;52(5):348-52
pubmed: 25691505
Genet Med. 2016 Jan;18(1):13-9
pubmed: 25856668
Hum Mutat. 2013 Jun;34(6):847-52
pubmed: 23483711
J Clin Oncol. 2019 Feb 20;37(6):461-470
pubmed: 30608896
Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):404-412
pubmed: 27799157
Genomics Proteomics Bioinformatics. 2007 Feb;5(1):7-14
pubmed: 17572359
Clin Genet. 2017 Apr;91(4):507-519
pubmed: 27779754
Gut. 2018 Jul;67(7):1306-1316
pubmed: 28754778
J Med Genet. 2014 May;51(5):283-93
pubmed: 24556086
Gastroenterology. 2015 Oct;149(4):1017-29.e3
pubmed: 26116798
Genome Res. 2013 May;23(5):843-54
pubmed: 23382536

Auteurs

Richard Gallon (R)

Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.

Barbara Mühlegger (B)

Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.

Sören-Sebastian Wenzel (SS)

Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.

Harsh Sheth (H)

Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.

Christine Hayes (C)

Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.

Stefan Aretz (S)

Institute of Human Genetics, Biomedical Centre, University Hospital Bonn, Bonn, Germany.

Karin Dahan (K)

Centre de génétique humaine, Institut de pathologie et génétique (IPG), Gosselies, Belgium.

William Foulkes (W)

Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada.
Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Department of Medical Genetics, McGill University Health Centre, Montreal, Quebec, Canada.
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Christian P Kratz (CP)

Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.

Tim Ripperger (T)

Department of Human Genetics, Hannover Medical School, Hannover, Germany.

Amedeo A Azizi (AA)

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Hagit Baris Feldman (H)

The Genetics Institute, Rambam Health Care Campus, and The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

Anne-Laure Chong (AL)

Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Department of Medical Genetics, McGill University Health Centre, Montreal, Quebec, Canada.
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Ugur Demirsoy (U)

Department of Pediatric Oncology, Kocaeli University, Kocaeli, Turkey.

Benoît Florkin (B)

Department of Pediatrics, CHR Citadelle Hospital, University of Liège, Liège, Belgium.

Thomas Imschweiler (T)

Pediatric Oncology, Helios-Klinikum, Krefeld, Germany.

Danuta Januszkiewicz-Lewandowska (D)

Department of Pediatric Oncology, Hematology and Transplantation, Poznań University of Medical Sciences, Poznań, Poland.

Stephan Lobitz (S)

Department of Pediatric Oncology/Pediatric Hematology, Kliniken der Stadt Köln gGmbH, Children's Hospital Amsterdamer Strasse, Köln, Germany.

Michaela Nathrath (M)

Pediatric Hematology and Oncology, Klinikum Kassel, Kassel, Germany.
Department of Pediatrics, Pediatric Oncology Center , Technische Universität München, Munich, Germany.

Hans-Jürgen Pander (HJ)

Institut für Klinische Genetik, Olgahospital, Stuttgart, Germany.

Vanesa Perez-Alonso (V)

Pediatrics Department, University Hospital Doce de Octubre, i+12 Research Institute, Madrid, Spain.

Claudia Perne (C)

Institute of Human Genetics, Biomedical Centre, University Hospital Bonn, Bonn, Germany.

Iman Ragab (I)

Pediatrics Department, Hematology-Oncology Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Thorsten Rosenbaum (T)

Department of Pediatrics, Sana Kliniken Duisburg, Duisburg, Germany.

Daniel Rueda (D)

Hereditary Cancer Laboratory, University Hospital Doce de Octubre, i+12 Research Institute, Madrid, Spain.

Markus G Seidel (MG)

Research Unit Pediatric Hematology and Immunology, Division of Pediatric Hematology-Oncology, Department of Pediatrics and Adolescent Medicine, Medical University Graz, Graz, Austria.

Manon Suerink (M)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.

Julia Taeubner (J)

Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children´s Hospital, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany.

Stefanie-Yvonne Zimmermann (SY)

Department of Pediatric Hematology and Oncology, Children's Hospital, University Hospital, Frankfurt, Germany.

Johannes Zschocke (J)

Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.

Gillian M Borthwick (GM)

Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.

John Burn (J)

Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.

Michael S Jackson (MS)

Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.

Mauro Santibanez-Koref (M)

Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.

Katharina Wimmer (K)

Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH